Showing results (631-640 of 1,795) with videos related to

Sort By:
Pageof 180
The EMBO Journal|July 16, 1999
Crystal structure of plant aspartic proteinase prophytepsin: inactivation and vacuolar targetingJ Kervinen, G J Tobin, J Costa, et al.
Revista Clinica Espanola|July 1, 1989
[Evaluation of diabetes knowledge in patients with insulin-dependent diabetes mellitus. Influential factors and analysis of its relation with blood glucose control]C J Costa Mestanza, I Fernández Fernández, I Carmona de Torres, et al.
Antimicrobial Agents and Chemotherapy|November 23, 2006
Development of a new methodology for screening of human immunodeficiency virus type 1 microbicides based on real-time PCR quantificationRenato S Aguiar, Luciana J Costa, Helena S Pereira, et al.
The Journal of Physical Chemistry. B|August 10, 2010
Molecular dynamics study of a heteroditopic-calix[4]diquinone-assisted transfer of KCl and dopamine through a water-chloroform liquid-liquid interfaceSérgio M Santos, Paulo J Costa, Michael D Lankshear, et al.
European Journal of Biochemistry|April 30, 1990
Dibucaine interaction with phospholipid vesicles. A resonance energy-transfer studyA Coutinho, J Costa, J L Faria, et al.
Inorganic Chemistry|September 7, 2018
Accurate Description of Low-Lying Excited States in a Series of Photoreactive Clusters [Os3(CO)10(α-diimine)] by DFT CalculationsFrantišek Hartl, Maarten J Bakker, Vanessa F Santos, et al.
Plos One|April 22, 2014
HIV-1 Nef inhibits Protease activity and its absence alters protein content of mature viral particlesLuiza M Mendonça, Sandro C Poeys, Celina M Abreu, et al.
Biochimica Et Biophysica Acta|January 24, 2016
Osteoclastogenic differentiation of human precursor cells over micro- and nanostructured hydroxyapatite topographyJ Costa-Rodrigues, S Carmo, I P Perpétuo, et al.
Chemico-Biological Interactions|June 28, 2022
Male reproductive toxicity of inorganic nanoparticles in rodent models: A systematic reviewGraziela P F Dantas, Fausto S Ferraz, Lídia M Andrade, et al.
British Journal of Haematology|June 14, 2016
Phase Ib trial of the PI3K/mTOR inhibitor voxtalisib (SAR245409) in combination with chemoimmunotherapy in patients with relapsed or refractory B-cell malignanciesFarrukh T Awan, Lia Gore, Lei Gao, et al.
Pageof 180